Rules for compliance
All materials displayed at SupplySide events are subject to the SupplySide Compliance Program. This includes, but is not limited to: booth displays, package labeling and inserts, descriptions of ingredients and services, promotional materials, websites, videos or anything presented at the show.
Prohibited claims
Product information being disseminated at any SupplySide event must meet the following standards:
- Promotion of a product to treat, prevent, mitigate or cure any disease or condition including but not limited to diabetes, cancer, flu, cold, heart disease or Alzheimer's disease is not permitted unless the product has received FDA drug approval.
- Claims based on traditional use must clearly communicate that the sole basis for the claim is its history of use for a particular purpose. Note that traditional use is a recognized form of substantiation for structure/function claims only — it does not authorize disease claims, which remain prohibited regardless of the basis for the claim.
- Under the FDCA (Federal Food, Drug and Cosmetic Act) and the DSHEA (Dietary Supplement Health & Education Act) ingredient claims must be appropriate for the intended application and use of the product. Products may not be promoted as a “drug” or with drug-like claims under these regulations unless the product has received FDA drug approval.
Claims that are a high priority for FDA include (but are not limited to): weight loss, body building, sexual enhancement and products for children. For more information about claims that can be made for conventional foods and dietary supplements, click here.
Prohibited ingredients
Ingredients prohibited in the United States include, but are not limited to: ephedra/ephedrine, anabolic steroids and their precursors, masking agents, narcotics, kratom, and drug ingredients marketed in food, beverage, dietary supplement applications.
For more information on industry information and regulations, click here.
Prevention of Adulterated Products
Adulteration is a global problem affecting consumer safety. Under federal Good Manufacturing Practice (GMP) regulations, manufacturers are required to test for adulteration — this is not optional. While SupplySide does not conduct independent testing at our events, we strongly encourage all buyers and sellers to familiarize themselves with the Botanical Adulterants Prevention Program (BAPP) and its Best Practices. See the BAPP section below for more information and links. To learn more about BAPP, click here.
SupplySide's hemp and cannabinoid policy
The SupplySide Compliance Program has adopted this policy for products that contain hemp and hemp-derived cannabinoids to help ensure the industry complies with existing regulations and to encourage best practices that help ensure quality and transparency. Acceptance as an exhibitor or advertiser and approval for exhibition or advertisement of any cannabinoid product at a SupplySide event is NOT a determination that the product complies with all local, state and federal laws, all of which may vary. Neither is it, nor is it intended to be, legal advice; exhibitors should always seek the advice of a qualified attorney.
Review criteria*:
When reviewing cannabinoid products, our highest priorities are safety, transparency, truthfulness, reliability and responsibility.
1. Hemp-derived, full spectrum products cannot contain more than 0.3% THC and may not exceed the THC limits of the state where the event is held.
2. Disease claims and all claims explicitly rejected by FDA, e.g. pain, chronic anxiety, etc. are prohibited.
3. Products may not be marketed for psychoactive, high, social buzz, etc. effects. THC focused products will not be accepted. Cannabis-derived (non-hemp) extracted ingredients are not accepted. Other non-hemp botanicals marketed for intoxicating, psychotropic, or alcohol-like effects are also not acceptable.
4. All statements must be substantiated.
5. Transparency, clarity and truthfulness in labeling are required.
6. Responsibility and care for vulnerable populations are required.
7. Vapes and vape accessories are prohibited.
8. Devices, including patches, are required to have appropriate FDA clearance (510k, PMA, registration and/or listing).
9. Exhibit review and approval is on a product-by-product basis.
*Violation of this show policy resolution will be considered a material violation of the show event rules and regulations and may result in the exhibitor’s removal from the venue at the venue's or show host management’s sole and absolute discretion.
Prohibited use of FDA logo
The FDA logo is for the official use of FDA and not for use on private sector materials. To the public, such use would send a message that FDA favors or endorses a private sector organization or the organization’s activities, products, services and/or personnel (either overtly or tacitly), which FDA does not and cannot do. Unauthorized use of the FDA logo may violate federal law and subject those responsible to civil and/or criminal liability.
For more information on the use of the FDA logo, click here.
